NCT06278298
Active, not recruiting
Not Applicable
Different Levels of Energy of Extracorporeal Shock Wave Therapy in Post Masrectomy Lymphedema
ConditionsLymphedema of Upper Limb
Overview
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Cairo University
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- lymphedema volume
Overview
Brief Summary
to investigate the effectiveness of different dosages of ECSW in the treatment of post mastectomy lymphedema volume and quality of life (Qol)
Detailed Description
The treatment program included two sessions per week for eight weeks. This study was approved by the ethical committee faculty of Physical Therapy Cairo University. All patients signed a consent form involves their agreement to participate in this study.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 30 Years to 60 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Criteria of selecting the patients from hospital included the following;
- •Their ages ranged from 30 to 50 years.
- •All patients were examined carefully by physician before the study procedure.
- •All patients were free from any other pathological conditions or histories of other health abnormalities except arm lymphedema.
- •They had undergone radical or modified radical mastectomy with axillary lymph node dissection with or without radiotherapy intervention.
- •Only ambulant subjects without any aides will be selected.
- •The degree of lymphedema in all subjects was grade 2 to 3 according to the classification of Foldi.(Foldi et al., 2006), (Appendix II ).
- •All patients will be medically stable.
- •Each patient will sign a consent form which in that insures her eligibility in the study.
- •All patients were treated by the same doctor and physiotherapist.
Exclusion Criteria
- •The subjects had been excluded from the study if they met one of the following criteria;
- •The patients had recurrent malignancy, active infection, and clinical evidence of obstructive venous diseases.
- •Patients contraindicated to ESWT due to bilateral, acute, and chronic inflammation as well as due to metastasis and poor skin condition were excluded.
- •The patients had neurological or orthopedic problems, and diabetes.
- •Patients with primary lymphedema.
- •Cardiopulmonary disease which decrease the patient activites.
Outcomes
Primary Outcomes
lymphedema volume
Time Frame: two months
tape measurment
skin thickness of the arm
Time Frame: two months
ultrasonography
Secondary Outcomes
No secondary outcomes reported
Investigators
Christina Sabry
Senior Physical Therapist
Cairo University
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Extracorporeal Shock Wave Therapy on Diabetes Related Frozen ShoulderFrozen ShoulderDiabetes MellitusNCT03185078Okan University39
Completed
Not Applicable
Can Extracorporeal Shock Wave Therapy Be Effective in Temporomandibular Joint DiseaseTemporomandibular Joint Disc Displacement, With ReductionExtracorporeal Shock Wave TherapyNCT05599113Yuzuncu Yıl University80
Completed
Not Applicable
Comparison of Low-intensity Extracorporeal Shockwave Therapy and Low-intensity Laser Effects in Adhesive CapsulitisAdhesive CapsulitisNCT05689593Ahi Evran University Education and Research Hospital65
Unknown
Not Applicable
Effect of Eswt on Muscle ArchitectureTendinopathyNCT04410705Hacettepe University20
Completed
Not Applicable
The Effects of Extracorporeal Shock Wave Therapy in Patients With Coccydynia: A Randomized Controlled TrialCoccydyniaNCT02313324Kaohsiung Medical University Chung-Ho Memorial Hospital42